Academic Journals Database
Disseminating quality controlled scientific knowledge

Retrovirology

ISSN: 1742--4690
Publisher: BioMed Central


ADD TO MY LIST
 
OAO5-04. Gp96-Ig-SIV vaccines induce predominant immune responses at mucosal sites

Author(s): Strbo N | Vaccari M | Pahwa S | Kolber MA | Fisher E | Gonzalez L | Felber BK | Pavlakis GN | Franchini G | Podack ER
Volume: 6
Issue: Suppl 3
Year: 2009
OA05-03. Efficacy study of a T-cell-based DNA vaccine delivered by intradermal electrotransfer in macaques

Author(s): Dereuddre-Bosquet N | Baron M | Méderlé-Mangeot I | Kaldma K | Sikut R | Männik A | Stanescu I | Ustav M | Le Grand R | Martinon F
Volume: 6
Issue: Suppl 3
Year: 2009
OA05-02. Analysis of DNA compared to Ad5 vaccination, as single and mixed modalities, demonstrates robust induction of cellular immune responses in macaques

Author(s): Hirao LA | Wu L | Satishchandran A | Khan AS | Finnefrock A | Casimiro D | Shiver J | Betts MR | Sardesai NY | Weiner DB
Volume: 6
Issue: Suppl 3
Year: 2009
OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers

Author(s): Vasan S | Hurley A | Schlesinger SJ | Hannaman D | Gardiner DF | Dugin DP | Boente-Carrera MM | Vittorino RM | Caskey M | Andersen J | Huang Y | Cox J | Tarragona T | Gill DK | Cheeseman H | Clark L | Dally L | Smith C | Schmidt C | Park H | Sayeed E | Gilmour J | Fast P | Bernard R | Ho DD
Volume: 6
Issue: Suppl 3
Year: 2009
OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial

Author(s): Kim JH | Kamasuta C | Trichavaroj R | Kaewkungwal J | Chantakulkij S | Ratto-Kim S | Eamsila C | Sukwit S | Nitayaphan S | Pitsuttihum P | Michael NL | Chiu J | Rerks-Ngarm S | de Souza MS | Paris RM
Volume: 6
Issue: Suppl 3
Year: 2009
S011-06 OA. HIV specific T cell responses and response patterns associated with viral control independent of classical non-progessor HLA class I alleles

Author(s): Zuniga R | Mothe B | Llano A | Ibarrondo J | Daniels M | Farfan M | Suarez J | Szinger JJ | Hildebrand W | Lucchetti A | Heckerman D | Goulder P | Walker BD | Sanchez J | Korber BT | Brander C
Volume: 6
Issue: Suppl 3
Year: 2009
OA04-05. Safety and viral load changes in HIV-1 infected subjects treated with autologous dendritic immune therapy following ART discontinuation (CTN#239)

Author(s): Routy J | Boulassel M | Mona L | Sylvie V | Cécile T | Jonathan A | John G | Jean-Guy B | Fiona S | Renu J | Don H | Irina T | Charles N | Sékaly RP
Volume: 6
Issue: Suppl 3
Year: 2009
OA04-04. Perceived parental willingness for their adolescents to participate in future HIV prevention trials: a survey conducted amongst adolescents in Soweto

Author(s): Otwombe K | Dietrich J | Sikkema K | de Bruyn G | Watt M | Gray G
Volume: 6
Issue: Suppl 3
Year: 2009
OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial

Author(s): Currier JR | De Souza M | Ratto-Kim S | Paris R | Nguay V | Cox J | Earl P | Moss B | Sriplienchan S | Thongcharoen P | Kim J | Robb M | Michael N | Marovich M
Volume: 6
Issue: Suppl 3
Year: 2009
OA04-02. Strong HIV-specific CD4 and CD8 T-lymphocyte proliferation in HIV-1 DNA prime/modified vaccinia virus Ankara (MVA) heterologous boost vaccinees

Author(s): Nilsson C | Aboud S | Karlén K | Marovich M | Wahren B | Sandström E | Gaines H | Biberfeld G | Godoy-Ramirez K
Volume: 6
Issue: Suppl 3
Year: 2009
OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial

Author(s): Salmon-Céron D | Durier C | Desaint C | Cuzin | Surenaud M | Hénin Y | Lelièvre J | Bonnet B | Pialoux G | Poizot-Martin I | Ben Hamouda N | Jackson A | Flys C | Guérin C | Aboulker J | Choppin J | Launay O
Volume: 6
Issue: Suppl 3
Year: 2009
OA03-06 LB. Unique stimulatory properties of myeloid dendritic cells in individuals with "elite" HIV-1 control

Author(s): Huang J | Poole L | Burke P | Cung T | Trocha A | Pereyra F | Borges L | Lichterfeld M | Yu X
Volume: 6
Issue: Suppl 3
Year: 2009
OA031-05. HIV escape from natural killer cytotoxicity: Nef inhibits NKp44L expression on HIV-infected CD4+ T cells

Author(s): Fausther-Bovendo H | Sol-Foulon N | Schwartz O | Debre P | Vieillard V
Volume: 6
Issue: Suppl 3
Year: 2009
OA031-04. Impairment of HIV-1-specific CD8+ T cell function by soluble epithelial adhesion molecules

Author(s): Streeck H | Kwon D | Jolin JS | Trocha K | Chevalier M | Caron T | Law K | Pyo A | Toth I | Kaufmann DE | Rodig SJ | Walker BD | Altfeld M
Volume: 6
Issue: Suppl 3
Year: 2009
OA031-03. Increased regulatory T cell frequency and HIV-1 specific suppression after therapeutic vaccination of HIV-infected patients on antiretroviral therapy

Author(s): Macatangay BC | Szajnik ME | Whiteside TL | Riddler SA | Rinaldo CR
Volume: 6
Issue: Suppl 3
Year: 2009
OA031-02. Regulatory T cells inhibit CD8 T cell proliferation in HIV-1 infection through CD39/adenosine pathway

Author(s): Nikolova M | Carriere M | Lelievre J | Muhtarova M | Bensussan A | Lévy Y
Volume: 6
Issue: Suppl 3
Year: 2009
S011-05 OA. HLA-A*7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, Tanzania

Author(s): Koehler RN | Walsh AM | Saathoff E | Currier JR | Bautista CT | Moqueet N | Ratto-Kim S | Maboko L | Hoelscher M | Robb ML | Michael NL | McCutchan FE | Kim JH | Kijak GH
Volume: 6
Issue: Suppl 3
Year: 2009
OA031-01. HIV-1 infection is characterized by early loss of CD161+ Th17 cells and gradual decline in regulatory T cells

Author(s): Prendergast A | Prado JG | Kang Y | Chen F | Riddell LA | Luzzi G | Goulder P | Klenerman P
Volume: 6
Issue: Suppl 3
Year: 2009
OA02-06 LB. Recombinant modified Vaccinia virus ankara expressing HIV-1 genes activates NK subset capable of controlling HIN infection in vitro

Author(s): Cummings J | Arnold V | Yarbrough K | Didier C | Levy Y | Barré-Sinoussi F | Scott-Algara D
Volume: 6
Issue: Suppl 3
Year: 2009
OA021-05. Insertion of the HIV-1 gp41 epitopes 2F5 and 4E10 into the membrane-proximal region of the vesicular stomatitis virus glycoprotein

Author(s): Lorenz IC | Nguyen HT | Phogat SK | Kaminsky SM | Zamb TJ | Parks CL
Volume: 6
Issue: Suppl 3
Year: 2009
OA021-04. HIV-1 gp41 envelope MPER mutation altered epitope conformation in lipid and increased sensitivity to 2F5 and 4E10 neutralizing antibodies

Author(s): Shen X | Dennison M | Gao F | Montefiori DC | Verkoczy L | Haynes B | Alam M | Tomaras G
Volume: 6
Issue: Suppl 3
Year: 2009
OA021-03. Design and development of DNA vaccines for the co-expression of micro-RNA and HIV-1 Env

Author(s): Wheatley AK | Alexander MR | Toe JG | Center RJ | Purcell DF
Volume: 6
Issue: Suppl 3
Year: 2009
OA021-02. Replicating measles-SHIV vaccine induces long term preservation of central memory CD4 cells in the gut of vaccinated macaques challenged with SHIV

Author(s): Tangy F | Février M | Guerbois M | Combredet C | Najburg V | Ruffié C | Morris A | Schwartz O | Legrand R
Volume: 6
Issue: Suppl 3
Year: 2009
OA021-01. Construction and characterization of replication competent attenuated NYVAC-based vectors as potential HIV vaccines

Author(s): Jacobs B | Kibler K | Wong S | Huynh T | Holechek S | Denzler K | Arndt W | Parrington M | Tartaglia J | Pantaleo G
Volume: 6
Issue: Suppl 3
Year: 2009
OA01-06 LB. HIV-1 plasma RNA and risk of HIV-1 transmission

Author(s): Lingappa JR | Hughes JP | Donnel D | Baeten JM | Mullins JI | Campbell MS | Gray GE | Essex M | Farquhar C | Rees H | Wald A | Corey L | Celum C
Volume: 6
Issue: Suppl 3
Year: 2009
P09-07. Balancing reversion of CTL and neutralizing antibody escape mutations within HIV-1 Env upon transmission

Author(s): Peut V | Campbell S | Gaeguta A | Center RJ | Alcantara S | Fernandez C | Purcell DF | Kent SJ
Volume: 6
Issue: Suppl 3
Year: 2009
P02-07. High concentrations of interleukin-15 and low concentrations of CCL5 in breast milk are associated with protection against postnatal HIV transmission

Author(s): Walter J | Ghosh MK | Kuhn L | Semrau K | Sinkala M | Kankasa C | Thea DM | Aldrovandi GM
Volume: 6
Issue: Suppl 3
Year: 2009
P09-06. HIV-1 escape from broadly neutralizing anti-CD4 binding site NAbs during HIV-1 infection

Author(s): Sather D | Kraft Z | Stamatatos L
Volume: 6
Issue: Suppl 3
Year: 2009
P09-05. Mechanism of HIV-1 resistance to a monoclonal antibody that effectively targets the site of CD4 attachment

Author(s): Wu X | Zhou T | O'Dell S | Wyatt RT | Kwong PD | Mascola JR
Volume: 6
Issue: Suppl 3
Year: 2009
P09-04. Charge changes in the alpha2-helix in the C3 region of the HIV-1 subtype C envelope mediate neutralization escape

Author(s): Moore PL | Ranchobe N | Lambson B | Gray E | Mlisana K | Karim S | Williamson C | Gnanakaran S | Morris L
Volume: 6
Issue: Suppl 3
Year: 2009
P09-02. Selection pressure of neutralizing antibodies and viral escape continues in late stages of the disease

Author(s): Rusert P | Krarup A | Joos B | Uhr T | Weber J | Herbert K | Guenthard HF | Trkola A
Volume: 6
Issue: Suppl 3
Year: 2009
P09-01. Mutation of the gp120 alpha2 helix in early subtype C HIV-1 infection fails to alter neutralization sensitivity or efficiency of in vitro replication

Author(s): Murphy MK | Rong R | Li B | Mulenga J | Allen SA | Gnanakaran S | Derdeyn CA
Volume: 6
Issue: Suppl 3
Year: 2009
P08-05. Does increased expression of HLA-C allow better control of HIV-1 viral load?

Author(s): Brackenridge S | Corrah T | Haygreen E | Lavender K | Dong T | Goonetilleke N | Borrow P | McMichael A
Volume: 6
Issue: Suppl 3
Year: 2009
P08-04. The role of class I HLA-B and HLA-Cw in disease progression and maternal-infant HIV-1 transmission in a South African population

Author(s): Paximadis M | Minevich G | Winchester R | Schramm DB | Gray GE | Sherman GG | Coovadia AH | Kuhn L | Tiemessen CT
Volume: 6
Issue: Suppl 3
Year: 2009
P08-03. Genetic complexity of TRIM5 and APOBEC in East Africa

Author(s): Walsh AM | Perret K | Koehler R | Moqueet N | Bautista C | Eller L | Eller M | Kibuuka H | Hoelscher M | Maboko L | Wabwire-Mangen F | Robb ML | Michael NL | McCutchan F | Kim J | Kijak GH
Volume: 6
Issue: Suppl 3
Year: 2009
P08-02. Genetic variation within the gene encoding the HIV-1 CCR5 coreceptor in two South African population groups

Author(s): Picton AC | Paximadis M | Tiemessen CT
Volume: 6
Issue: Suppl 3
Year: 2009
P02-06. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine

Author(s): Liu J | Ngai N | Stone GW | Yue F | Ostrowski MA
Volume: 6
Issue: Suppl 3
Year: 2009
P08-01. Heme oxygenase-1 promoter polymorphisms correlate with favorable virologic and immunological parameters in HIV-1 infection

Author(s): Seu L | Burt TD | Williamson DW | Martin JN | Deeks SG | McCune JM
Volume: 6
Issue: Suppl 3
Year: 2009
P07-10. Natural compounds in bodily fluids which bind DC-SIGN and prevent HIV-1 capture and transfer to CD4 cells

Author(s): Stax MJ | Pollakis G | Sprenger RR | Melchers M | van Montfort T | Sanders RW | Speijer D | Paxton WA
Volume: 6
Issue: Suppl 3
Year: 2009
P07-09. Contemporaneous transmission of genetically distinct HIV variants from a single donor to two recipients

Author(s): English S | Katzourakis A | Flanagan P | Duda A | Francis J | Matthews P | Prendergast A | Goulder P | Fidler S | Weber J | McClure M | Phillips R | Frater J
Volume: 6
Issue: Suppl 3
Year: 2009
P07-08. Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells

Author(s): Lenicov F | Sabatté J | Rodrígues C | Cabrini M | Jancic C | Raiden S | Donalson M | Pasqualini R | Marin-Briggiler C | Vásquez-Levin M | Capani F | Amigorena S | Geffner J | Ceballos A
Volume: 6
Issue: Suppl 3
Year: 2009
P07-07. Non-progressive paediatric HIV infection is associated with virus attenuation and increase in CD8+ specific T cell responses over time

Author(s): Prado JG | Prendergast A | Thobakgale C | Juarez C | Tudor-Williams A | Ndung'u T | Walker BD | Goulder P
Volume: 6
Issue: Suppl 3
Year: 2009
P07-06. HIV-1 transmission and early evolution: whole genome analysis

Author(s): Herbeck JT | Rolland MT | Deng WC | Collier AC | Mullins JI
Volume: 6
Issue: Suppl 3
Year: 2009
P07-05. HIV and STI prevalence among men who have sex with men (MSM) recruited through respondent driven sampling (RDS) in Buenos Aires, Argentina

Author(s): Pando M | Marone R | Balan I | Dolezal C | Squiquera L | Picconi A | Gonzales J | Rey J | Toscano M | Fermepin M | Vaulet L | Dieguez A | Avila MM
Volume: 6
Issue: Suppl 3
Year: 2009
P07-04. HIV-1 evolution in mother to child transmission and pediatric disease progression

Author(s): Dispinseri S | Cavarelli M | van Nuenen A | Schuitemaker H | Scarlatti G
Volume: 6
Issue: Suppl 3
Year: 2009
P07-02. Cytotoxic T lymphocyte-mediated immune responses in HIV-1 clade C infected mother-child pairs

Author(s): Moodley ES | Thobakgale C | Ramkalawon P | Vanderstok M | Mncube Z | Bishop K | Reddy S | Chonco F | Walker B | Goulder P | Ndung'u T
Volume: 6
Issue: Suppl 3
Year: 2009
P01-01. The blood transcriptional response to early acute HIV infection is transient and responsive to antiretroviral therapy

Author(s): Skinner JA | Sharma M | Baldwin N | Lemoine B | Blankenship D | De Vol EB | Mejias A | Ramilo O | Cohen M | Letvin N | Goldstein D | Soderberg K | Denny TN | Shianna K | McMichael A | Haynes B | Banchereau J | Chaussabel D
Volume: 6
Issue: Suppl 3
Year: 2009
OA011-03. Clusterin, a natural ligand of DC-SIGN present in human semen inhibits HIV capture and transmission by dendritic cells

Author(s): Sabatte J | Faigle W | Ceballos A | Morelle W | Rodríguez C | Lenicov F | Thépaut M | Fieschi F | Lortat-Jacob H | Michalski J | Arenzana-Seisdedos F | Geffner J | Amigorena S
Volume: 6
Issue: Suppl 3
Year: 2009
OA011-02. Defining the mechanisms of HIV entry and interactions with the female genital tract

Author(s): Carias AM | McCoombe S | McRaven M | Anderson M | Veazey R | Hope TJ
Volume: 6
Issue: Suppl 3
Year: 2009
OA011-01. Early events of human immunodeficiency virus type 1 (HIV-1) ex vivo penetration in the foreskin mimicking HIV-1 sexual transmission

Author(s): Ganor Y | Zhou Z | Schmitt A | Vacher-Lavenu M | Gibault L | Thiounn N | Tomasini J | Wolf J | Bomsel M
Volume: 6
Issue: Suppl 3
Year: 2009
S021-06 OA. Potent and broad neutralizing antibodies from HIV-1 non-clade B infected donor reveal a new HIV-1 vaccine target

Author(s): Phogat SK | Walker L | Wagner D | Chan-Hui P | Simek M | Phung P | Wrin T | Mitcham J | Investigator P | Kaminsky S | Zamb T | Moyle M | Koff W | Burton D
Volume: 6
Issue: Suppl 3
Year: 2009
OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial

Author(s): de Souza MS | Trichavaroj R | Schuetz A | Chuenarom W | Phuang-ngem Y | Jongrakthaitae S | Ratto-Kim S | Nitayaphan S | Dally L | Rerks-Ngam S | Tartaglia J | Francis D | Michael NL | Paris RM | Kim JH
Volume: 6
Issue: Suppl 3
Year: 2009
OA07-03. Influence of preexisting vaccinia immunity on a DNA/MVA SIV vaccine, decreased cellular immunity but enhanced control of a pathogenic SIV challenge

Author(s): Kannanganat S | Nigam P | Velu V | Earl P | Lai L | Lawson B | Chennareddi L | Wilson R | Kozlowski P | Moss B | Robinson H | Amara R
Volume: 6
Issue: Suppl 3
Year: 2009
OA07-02. Adenovirus vectors induce expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1 infection

Author(s): Benlahrech A | Harris J | Meiser A | Papagatsias T | Hornig J | Hayes P | Lieber A | Athanasopoulos T | Bachy V | Daniels R | Fisher K | Gotch F | Klavinskis L | Seymour L | Logan K | Barbagallo R | Dickson G | Patterson S
Volume: 6
Issue: Suppl 3
Year: 2009
S021-05 OA. Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface

Author(s): Song L | Sun ZJ | Coleman KE | Zwick MB | Gach JS | Wang J | Reinherz EL | Wagner G | Kim M
Volume: 6
Issue: Suppl 3
Year: 2009
0A07-01. HIV-specific CD8+ T-cells of vaccinees exhibit proliferative and cytotoxic capacities comparable to those of progressors

Author(s): Rood JE | Migueles SA | Berkley AM | Compton AA | Joshi RP | Duerr A | McElrath J | Connors M
Volume: 6
Issue: Suppl 3
Year: 2009
S04-06 OA. Polyvalent Gag-specific CD8 T-cells with enhanced functional properties are enriched in HIV-1 clade C infected individuals with lower viral loads

Author(s): Julg B | Williams KL | Reddy S | Bishop K | Goulder PJ | Ndung'u T | Walker BD
Volume: 6
Issue: Suppl 3
Year: 2009
SO4-05 OA. The intracellular production of HIV antigenic peptides is guided by predictable motifs and can be altered: implications for immunogen design

Author(s): Lazaro E | Zhang S | Zhang M | Martinez S | Heckerman D | Walker BD | Le Gall S
Volume: 6
Issue: Suppl 3
Year: 2009
S04-04 OA. HIV-specific responses induced by anti-CD40 targeting antibodies

Author(s): Loof N | Montes M | Flamar A | Zurawski G | Cobb A | Plants J | King B | Zurawski S | Sloan L | Levy Y | Banchereau J
Volume: 6
Issue: Suppl 3
Year: 2009
S03-06 OA. Rapid perforin upregulation by CD8 T cells in elite controllers as a correlate of immune-mediated control of HIV replication

Author(s): Hersperger AR | Pereyra F | Demers K | Sheth P | Shin LY | Rodriguez B | Sieg SF | Teixeira-Johnson L | Goepfert PA | Lederman MM | Kaul R | Makedonas G | Walker BD | Betts MR
Volume: 6
Issue: Suppl 3
Year: 2009
S03-05 OA. A less differentiated memory phenotype of Gag-specific CD4+ T-cells during primary HIV infection associates with viral control at 12 months

Author(s): Maenetje PW | Casazza J | Riou C | Ambrozak D | Gray G | de Bruyn G | Koup R | Gray C
Volume: 6
Issue: Suppl 3
Year: 2009
S03-04 OA. Transitional and central memory CD4 T cells are highly infected in long term non progressors and elite controllers

Author(s): Descours B | Avettand-Fenoël V | Blanc C | Samri A | Mélard A | Prazuck T | Hocqueloux L | Carcelain G | Rouzioux C | Autran B
Volume: 6
Issue: Suppl 3
Year: 2009
OA06-06 LB. Evidence of vaccine-induced changes in breakthrough HIV-1 strains from the Step trial

Author(s): Rolland M | Tovanabutra S | Gilbert PB | Sanders-Buell E | Heath L | deCamp AC | Magaret CC | Bose M | Bradfield A | O'Sullivan A | Crossler J | Deng W | Zhao H | Wong K | Raugi DN | Hural J | Dubey S | Frahm N | Michael NL | Shiver J | Corey L | Li F | Self SG | Kim J | Buchbinder S | Casimiro DR | Robertson MN | McElrath MJ | McCutchan FE | Mullins JI
Volume: 6
Issue: Suppl 3
Year: 2009
OA06-05. Adaptation of HIV-1 to the human immune system at the population level is driven by protective HLA-B alleles

Author(s): Schellens IM | Navis M | van Deutekom HW | Boeser-Nunnink B | Berkhout B | Kootstra N | Miedema F | Kesmir C | Schuitemaker H | van Baarle D | Borghans JA
Volume: 6
Issue: Suppl 3
Year: 2009
OA06-04. The role of early T-cell responses in subjects with acute HIV-1 infection

Author(s): Liu MK | Ferrari G | Salazar J | Keele B | Tanner RL | Hraber P | Giorgi E | Ganusov VV | Learn GH | Salazar MG | Moore SR | Digleria K | Yu Z | Rostron T | DeBoer C | Williams A | Margaret C | Kopycinski J | Campion SL | Bourne VE | Brackenridge S | Hahn B | Cohen M | Borrow P | Weinhold K | Perelson A | Shaw G | Korber BT | Goonetilleke N | McMichael AJ
Volume: 6
Issue: Suppl 3
Year: 2009
S021-04 OA. A large-scale analysis of immunoglobulin sequences derived from plasmablasts/plasma cells in acute HIV-1 infection subjects

Author(s): Munshaw S | Liao H | Dixon A | Chen X | Nagel A | Derosa K | Parks R | Amos J | Whitesides JF | Marshalls DJ | Yang Y | Gao F | Tomaras GD | Moody MA | Kelsoe GH | Shea TC | Margolis DM | Markowitz M | Goepfert P | Shaw G | Haynes BF | Kepler TB
Volume: 6
Issue: Suppl 3
Year: 2009
OA06-03. Dynamics of CTL epitope escape and reversion in an African subtype C cohort

Author(s): Schaefer M | Mulenga J | Tang J | Goepfert P | Farmer P | Kaslow R | Allen S | Hunter E
Volume: 6
Issue: Suppl 3
Year: 2009
OA06-02. Monospecific expansion of SIVmac251 during acute infection masks multiple transmitted virus variants revealed during the chronic phase

Author(s): Felber BK | Kim E | Pal R | Desrosiers RC | Wolinsky SM | Pavlakis GN
Volume: 6
Issue: Suppl 3
Year: 2009
0A06-01. Multiplicity of infection by HIV-1 in injection drug users, men who have sex with men and heterosexuals

Author(s): Bar KJ | Li H | Keele B | Grayson T | Sun R | Chamberland A | Tremblay C | Markowitz M | Schumacher J | Hahn B | Shaw G
Volume: 6
Issue: Suppl 3
Year: 2009
OA05-06 LB. First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector

Author(s): Baden LR | Dolin R | O'Brien KL | Abbink P | La Porte A | Seaman MS | Choi E | Tucker R | Weitjens M | Pau MG | Goudsmit J | Barouch DH
Volume: 6
Issue: Suppl 3
Year: 2009
OA05-05. Impact of in vivo CD4 binding during HIV-1 Env trimer immunizations of rhesus macaques

Author(s): Douagi I | Forsell MM | Sundling C | O'dell S | Seder R | Mascola JR | Loré K | Wyatt RT | Hedestam GB
Volume: 6
Issue: Suppl 3
Year: 2009
P11-21. Induction of persistent mucosal humoral and cellular responses following immunization of mice with HIV-1 envelope protein in inulin-derived adjuvants

Author(s): Cristillo AD | Ferrari G | Hudacik L | Thompson D | Bowen B | Lewis B | Galmin L | Suschak J | Petrovsky N | Markham P | Pal R
Volume: 6
Issue: Suppl 3
Year: 2009
P11-20. HIV-1 gp41-specific mucosal IgAs from highly exposed but IgG seronegative women block HIV-1 epithelial transcytosis and neutralize CD4+ cell infection

Author(s): Tudor D | Derrien M | Diomede L | Houimel M | Drillet A | Moog C | Reynes J | Lopalco L | Bomsel M
Volume: 6
Issue: Suppl 3
Year: 2009
P11-19. Altered mucosal distribution of SIV-specific T cells in Rhesus macaques infected with the live-attenuated Rev-independent SIV

Author(s): Valentin A | von Gegerfelt A | Alicea C | Patel V | Marthas ML | Van Rompay K | Pavlakis GN | Felber BK
Volume: 6
Issue: Suppl 3
Year: 2009
P11-18. Immunogenicity of Lactobacillus gasseri-FliC as an oral mucosal vaccine adjuvant for HIV

Author(s): Gunderson S | Nordone S | LaVoy A | Zhang L | Klaenhammer T | Dean G
Volume: 6
Issue: Suppl 3
Year: 2009
P11-17. Intermittent rectal shedding of multiple human adenovirus serotypes among HIV-positive MSM

Author(s): Curlin M | Celum C | Sanchez J | Selke S | Baeten J | Huang M | Zuckerman R | Lu X | Erdman D | Corey L
Volume: 6
Issue: Suppl 3
Year: 2009
P11-16. Transfer of HIV-1 from Langerhans and interstitial dendritic cells to T lymphocytes: protection mediated by antibodies?

Author(s): Peressin M | Holl V | Schmidt S | Decoville T | Penichon J | Moog C
Volume: 6
Issue: Suppl 3
Year: 2009
P11-15. Induction of a mucosal immune response to HIV after systemic immunization with poly(lactic acid) nanoparticles formulated with gag antigen and polyI:C

Author(s): Primard C | Weber C | Martinon F | Munier S | Calamel A | Luciani E | Delair T | Le Grand R | Verrier B
Volume: 6
Issue: Suppl 3
Year: 2009
P02-11. Correlate of local adjuvanticity and inflammation for experimental vaginal adjuvants in mice

Author(s): Lindqvist M | Navabi N | Jansson M | Sjöling Å | Örndal C | Harandi AM
Volume: 6
Issue: Suppl 3
Year: 2009
P11-14. Analysis of mucosal antibodies in genital fluids of HIV seropositive subjects from Cambodian and Italian cohorts

Author(s): Lopalco L | Scotti L | Pastori C | Ngyen M | Nouhin J | Ferrari D | Pancino G
Volume: 6
Issue: Suppl 3
Year: 2009
P11-13. Antigen presentation and immune priming of CCR5-ECL1 receptor in Peyer's patches B cells

Author(s): Lopalco L | Diomede L | Pastori C | Soprana E | Siccardi A
Volume: 6
Issue: Suppl 3
Year: 2009
P11-12. A novel vaginal ring device for the sustained delivery of recombinant C-clade HIV-1 CN54gp140

Author(s): Morrow RJ | Donnelly L | Curran RM | Malcolm RK | Woolfson AD | Andrews GP | Shattock R
Volume: 6
Issue: Suppl 3
Year: 2009
P11-11. Stable lyophilised gel vehicles for vaginal administration of recombinant C-clade HIV-1 trimeric CN54gp140

Author(s): Donnelly L | Curran RM | Morrow RJ | Kett VL | Andrews GP | Malcolm RK | Woolfson AD | Shattock RJ
Volume: 6
Issue: Suppl 3
Year: 2009
P11-10. Modulation of intestinal T cells following infection of macaques with live attenuated and conditionally replication-competent SIV

Author(s): Manoussaka MS | Stebbings R | Quartey-Papafio R | Robinson M | Page M | Das AT | Kleibeuker W | Klaver B | Berkhout B | Almond N | Cranage M
Volume: 6
Issue: Suppl 3
Year: 2009
P11-09. Mucosal vaccination with a transferrin-gp140 conjugate via the nasal but not vaginal route elicits robust systemic and vaginal IgG and IgA responses

Author(s): Mann JF | de Stegmann DS | Klein K | Stieh D | Cranage MP | Shattock RJ | McKay PF
Volume: 6
Issue: Suppl 3
Year: 2009
P11-08. Abstract withdrawn

Volume: 6
Issue: Suppl 3
Year: 2009
P11-07. Characterization of a new TZM-bl cell line that expresses human FcαR(CD89)

Author(s): Perez LG | Costa MR | Montefiori DC
Volume: 6
Issue: Suppl 3
Year: 2009
P11-06. Intravaginal administration of HIV-1ZM96 gp140 augments systemic and mucosal antibody responses following systemic priming with adjuvanted protein

Author(s): Cranage M | Fraser C | Cope A | McKay P | Elsley W | Page M | Mahmoud AN | DaCosta K | Fletcher P | Armanasco N | Almond N | Shattock R
Volume: 6
Issue: Suppl 3
Year: 2009
P11-05. Induction of CD8+ T cell mediated immune responses through skin and mucosa: identification of immunostimulatory versus tolerogenic dendritic cells

Author(s): Dubois B | de Agüero M | Le Borgne M | Gouanvic M | Vocanson M | Kaiserlian D
Volume: 6
Issue: Suppl 3
Year: 2009
P02-10. Plant expression of chimeric Gag/gp41 virus-like particles as a mucosally-targeted subunit vaccine against HIV-1

Author(s): Kessans SA | Frater J | Matoba N | Mor T
Volume: 6
Issue: Suppl 3
Year: 2009
P11-04. PEGylated poly [2-(N,N-dimethylamino) ethyl methacrylate] as mucosal DNA delivery vector improves HIV-1-specific immune responses

Author(s): Qiao Y | Huang Y | Yue XY | Qiu C | Deng LD | Wan YM | Xing JF | Zhang CY | Yuan SH | Dong AJ | Xu JQ
Volume: 6
Issue: Suppl 3
Year: 2009
P11-03. Mucosal trafficking and differentiation of vaccine-elicited CD8+ T-lymphocytes

Author(s): Kaufman DR | Simmons NL | Barouch DH
Volume: 6
Issue: Suppl 3
Year: 2009
P11-02. In situ analysis by confocal microscopy of the cellular components of mucosal tissues within the framework of preclinical vaccine studies

Author(s): Boggiano CA | Ginsberg AA | Reynolds MR | Wilson NA | Watkins DI | McDermott AB
Volume: 6
Issue: Suppl 3
Year: 2009
P11-01. Extensive intestinal damage underlies microbial translocation in the GI tract of chronically SIV-infected Rhesus macaques

Author(s): Harris LD | Estes JD | Klatt NR | Taft B | Barclay R | Douek DC | Silvestri G | Liffson J | Brenchley J
Volume: 6
Issue: Suppl 3
Year: 2009
P10-14. Dynamic profiling and correlation analysis of plasma viral load and cytokine and chemokine profiles in acute HIV-1 infection

Author(s): Qin L | Stacey A | Norris P | Wang P | Borrow P | Self SG
Volume: 6
Issue: Suppl 3
Year: 2009
P10-13. Increased production of alpha-defensins 1–3 by dendritic cells in HIV-infected individuals is associated with a slower disease progression rate

Author(s): Rodriguez-Garcia M | Climent N | Oliva H | Rovira C | Miralles L | Leon A | Gatell J | Garcia F | Gallart T
Volume: 6
Issue: Suppl 3
Year: 2009
P10-12. Altered NK cell phenotype and function in Ugandans with chronic HIV-1 infection

Author(s): Eller MA | Eller L | Koehler RN | Kijak GH | Guwatudde D | Marovich MA | Michael NL | de Souza MS | Wabwire-Mangen F | Robb ML | Currier JR | Sandberg JK
Volume: 6
Issue: Suppl 3
Year: 2009
P10-11. NK cells do not accumulate at sites of HIV-replication but show increased activation

Author(s): Luteijn R | Nolting A | van Lunzen J | Altfeld M | Alter G
Volume: 6
Issue: Suppl 3
Year: 2009
P10-10. HIV-1 Gag virus like particles pseudotyped with CD40 ligand to stimulate innate immune responses

Author(s): Köstler J | Bredl S | Sertl S | Wiesel M | Wild J | Wagner R
Volume: 6
Issue: Suppl 3
Year: 2009
P10-09. Altered release of RANTES from human, normal platelets: contribution of distinct HIV-1MN gp41 peptides

Author(s): Cognasse F | Hamzeh-cognasse H | Berthet J | Damien P | Lucht F | Pozzetto B | Garraud O
Volume: 6
Issue: Suppl 3
Year: 2009
P02-09. Dissecting the interference of endotoxins with HIV infection of primary CD4 T cell

Author(s): Krarup A | Rusert P | Trkola A
Volume: 6
Issue: Suppl 3
Year: 2009
P10-06. Adaptive immune responses elicited by recombinant adenovirus vectors exhibit partial MyD88 dependence

Author(s): Rhee EG | Kasturi SP | Pulendran B | Barouch DH
Volume: 6
Issue: Suppl 3
Year: 2009
P10-05. Suppression of human dendritic cell function during acute HIV infection

Author(s): Frleta D | O'Brien M | Haynes B | Kessler B | Bhardwaj N
Volume: 6
Issue: Suppl 3
Year: 2009
P10-04. Mechanisms of HIV-1 detection by plasmacytoid dendritic cells

Author(s): Lepelley A | Louis S | Sourisseau M | Perrin V | Mammano F | Albert M | Schwartz O
Volume: 6
Issue: Suppl 3
Year: 2009
P10-03. Dramatic changes in Fc-receptor expression during HIV-1 infection associated with reduced phagocytic activity during progressive HIV-1 infection

Author(s): Dugast AM | Tonelli A | Toth I | Piechocka-Trocha A | Alter G
Volume: 6
Issue: Suppl 3
Year: 2009
P10-02. Toll-like receptor activation profiles of wild-type, recombinant, and mutant Lactobacillus: implications for vaccine design

Author(s): Stoeker L | Nordone S | LaVoy A | Tallon R | Klaenhammer T | Dean G
Volume: 6
Issue: Suppl 3
Year: 2009
P10-01. MHC class I chain-related protein A shedding in chronic HIV-1 infection is associated with profound NK cell dysfunction

Author(s): Nolting A | Luteijn R | Dugast A | Carrington M | Rihn S | Kane K | Jost S | Toth I | Faetkenheuer G | Hartmann P | Altfeld M | Alter G
Volume: 6
Issue: Suppl 3
Year: 2009
P09-18. Cw*0303/0304 HIV specific CTL response toward GagYL9 select for HIV escape variants with low fitness that is compensated by intra-codon variation

Author(s): Honeyborne I | Leslie A | Crawford H | Rousseau CM | Mullins JI | Walker BD | Goulder P | Prado JG
Volume: 6
Issue: Suppl 3
Year: 2009
P09-17. Evolution of HLA-B*5703 HIV-1 escape mutations and their impact on HIV-1 replicative capacity

Author(s): Crawford H | Lumm W | Leslie A | Schaefer M | Boeras D | Prado J | Mulenga J | Allen S | Goulder P | Hunter E
Volume: 6
Issue: Suppl 3
Year: 2009
P02-08. Enhancement of HIV-1 DNA vaccine immunogenicity by BCG-PSN, a novel adjuvant

Author(s): Sun J | Liu Y | Li D | Hou J | Xu Z | Fan W | Fu J | Liu Y | Shao Y
Volume: 6
Issue: Suppl 3
Year: 2009
P09-16. A primary R5 isolate undergoes different escape pathway during in vitro selection with low or high concentration of an anti-V3 monoclonal antibody

Author(s): Narahara C | Hatada M | Shigeyoshi H | Yoshimura K | Matsushita S
Volume: 6
Issue: Suppl 3
Year: 2009
P09-15. Selection of higher avidity HLA-restricted T cell responses as a viral adaptation strategy

Author(s): Keane N | Roberts S | Laird R | Chopra A | Krishnan T | Almeida C | Bronke C | Mallal S | James I | John M
Volume: 6
Issue: Suppl 3
Year: 2009
P09-14. Emergence of b12 resistant rapidly replication HIV-1 variants during natural infection in the absence of humoral or cellular immune pressure

Author(s): Bunnik E | Lobbrecht M | Pisas L | van Nuenen A | Schuitemaker H
Volume: 6
Issue: Suppl 3
Year: 2009
P09-13. Structure of HIV-1 gp41 interactive region: layered architecture and basis of conformational mobility

Author(s): Pancera M | Majeed S | Ban Y | Chen L | Huang C | Kong L | Kwon Y | Stuckey J | Zhou T | Robinson J | Schief W | Sodroski J | Wyatt R | Kwong P
Volume: 6
Issue: Suppl 3
Year: 2009
P09-12. Autologous neutralizing antibodies in early subtype C HIV-1 infection target variable regions of envelope and drive multiple pathways of viral escape

Author(s): Rong R | Li B | Haaland RE | Murphy MK | Mulenga J | Allen SA | Blackwell JL | Pinter A | Shaw GM | Gnanakaran S | Hunter E | Robinson JE | Derdeyn CA
Volume: 6
Issue: Suppl 3
Year: 2009
P09-11. Reduced replication capacity of NL4-3 chimeric viruses encoding RT-Integrase sequences from HIV-1 elite controllers

Author(s): Li C | Brumme ZL | Miura T | Rosato PC | Sela J | Brumme CJ | Heckerman D | Pereyra F | Walker BD | Brockman MA
Volume: 6
Issue: Suppl 3
Year: 2009
P09-10. Impact of CTL escape mutations in HIV-1 Nef on viral replication

Author(s): Oniangue-Ndza C | Schneidewind A | Brockman MA | Brumme ZL | Boutwell CL | Wang YE | Brumme CJ | Power KA | Gladden AD | Kemper M | Le Gall S | Streeck H | Alter G | Altfeld M | Heckerman D | Walker BD | Allen TM
Volume: 6
Issue: Suppl 3
Year: 2009
P09-09. Impact of immune-driven sequence variation in HIV-1 subtype C Gag-Protease on viral fitness and disease progression

Author(s): Wright JK | Brockman MA | Brumme ZL | Walker BD | Goulder PJ | Ndung'u T
Volume: 6
Issue: Suppl 3
Year: 2009
P15-09. The potential global market size and public health value of hypothetical HIV-1 preventive vaccines with different levels of efficacy

Author(s): Marzetta CA | Wrobel SJ | Singh KK | Russell ND | Esparza J
Volume: 6
Issue: Suppl 3
Year: 2009
P03-04. Increased virulence of CAEV chimeras expressing Nef and Vpx/Vpr accessory proteins in infected goats

Author(s): Jin Y | Arrode-Brusés G | Halloway N | Narayan O | Chebloune Y
Volume: 6
Issue: Suppl 3
Year: 2009
P15-08. Did unblinding affect HIV risk behaviour and risk perception in the HVTN503/Phambili study?

Author(s): Gray GE | Bekker L | Churchyard G | Nchabeleng M | Mlisana K | de Bruyn G | Roux S | Mathebula M | Latka M | Bennie T | Metch B | Moodie Z | Allen M | Eaton N | Kublin J
Volume: 6
Issue: Suppl 3
Year: 2009
P15-07. Knowledge, attitudes, practices and willingness to participate in HIV vaccine trials among urban residents of Bamako, Mali, in West Africa, 2005–2009

Author(s): Tounkara K | Aboubacar B | Koita O | Traore A | Dao S | Moussa S | Ibrahima D | Fanta S | Bougoudogo F | Gerber R | De Groot AS
Volume: 6
Issue: Suppl 3
Year: 2009
P15-06. Brighton collaboration viral vector vaccines safety working group (V3SWG): maximizing the comparability and value of safety data from HIV vaccine trials

Author(s): Chen RT | Excler J | Laderoute MP | Mahy BW | Hendry MP | Via CM | Compingbutra AA | Gidudu J
Volume: 6
Issue: Suppl 3
Year: 2009
P15-05. Evaluation and recommendations on good clinical laboratory practice (GCLP) guidelines for phase I-III HIV vaccine clinical trials

Author(s): Sarzotti-Kelsoe M | Cox J | Cleland N | Denny T | Hural J | Needham L | Ozaki D | Rodriguez-Chavez IR | Stevens G | Stiles T | Tarragona-Fiol T | Simkins A
Volume: 6
Issue: Suppl 3
Year: 2009
P15-04. Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells

Author(s): Todd CA | Yu X | Ozaki DA | Greene KM | Gao H | Wood B | Wang M | Gilbert P | Montefiori DC | Sarzotti-Kelsoe M
Volume: 6
Issue: Suppl 3
Year: 2009
P15-03. HIV vaccine funding trends entering a global recession: research and development (R&D) from 2000 – 2008

Author(s): Fisher K | Feuer C | Harrison P | Lee W | Romero L | Vuthoori S | Warren M
Volume: 6
Issue: Suppl 3
Year: 2009
P15-02. Participation in immune-based therapy trial excludes participation in future trials: solving this problem

Author(s): Routy J | Lebouche B | Gilmore N
Volume: 6
Issue: Suppl 3
Year: 2009
P15-01. Willingness to participate in actual preventive HIV vaccine phase I/IIa trial in Bangkok, Thailand

Author(s): Hemachandra A | Puls RL | Kerr SJ | Saengthong N | Pussadee K | Emery S | Phanuphak P | Ruxrungtham K
Volume: 6
Issue: Suppl 3
Year: 2009
P14-13. Long-term follow-up of study participants in HIV prophylactic vaccine clinical trials in Africa

Author(s): Schmidt C | Jaoko W | Kaleebu P | Karita E | Lehrman | Allen S | Dally L | Smith C | Fast PE
Volume: 6
Issue: Suppl 3
Year: 2009
P14-12. Safety and tolerability of VRC DNA and rAd5 HIV-1 vaccine delivery by intramuscular, subcutaneous and intradermal administration in healthy adults

Author(s): Enama ME | Novik L | Holman L | Gordon I | Nason M | Ledgerwood J | Graham BS
Volume: 6
Issue: Suppl 3
Year: 2009
P03-03. Protection against SIV by anti HLA class II specific antibody in the macaque model

Author(s): Robinson MJ | Quartey-Papafio R | Almond N | Page M
Volume: 6
Issue: Suppl 3
Year: 2009
P01-02. Anti-inflammatory and regulatory mechanisms provide the context for an effective CD8+ T cell response in live-attenuated immunized animals

Author(s): Ferrer M | Ma M | Li J | Fritts L | McChesney MB | Miller CJ
Volume: 6
Issue: Suppl 3
Year: 2009
P14-11. Educating community medical providers about HIV vaccine induced seropositivity

Author(s): Mark KE | Maenza J | Garcia D | Louis K | Alexander SB | Moore E | Broder GB | Wakefield S | McElrath M
Volume: 6
Issue: Suppl 3
Year: 2009
P14-10. Comparable immunogenicity of VRC DNA and rAd5 HIV-1 vaccines delivered by intramuscular, subcutaneous and intradermal routes in healthy adults (VRC 011)

Author(s): Ledgerwood JE | Novik L | Enama ME | Gordon IJ | Holman LA | Nason MC | Bailer RT | Roederer M | Koup RA | Mascola JR | Nabel GJ | Graham BS
Volume: 6
Issue: Suppl 3
Year: 2009
P14-09. Use of HIV rapid tests for assessment of persistence of vaccine induced antibodies among HIV vaccine recipients

Author(s): Karita E | Kayitenkore K | Bayingana R | Sebahungu F | Bizimana J | Grabowski K | Tichacek A | Schmidt C | Fast P | Hunter E | Allen S
Volume: 6
Issue: Suppl 3
Year: 2009
P14-08. Intramuscular DNA delivery by electroporation leads to greatly enhanced systemic and mucosal immune responses and control of SIVmac251 challenge

Author(s): Pavlakis GN | Rosati M | Patel V | Valentin A | Bergamaschi C | Kulkarni V | Jalah R | von Gegerfelt A | Ohlen C | Khan A | Draghia-Akli R | Van Rompay K | Felber BK
Volume: 6
Issue: Suppl 3
Year: 2009
P14-07. Offering new prevention modalities in HIV vaccine trials: experience with male circumcision in the Phambili trial

Author(s): de Bruyn G | Mlisana K | Metch B | Churchyard G | Nchabeleng M | Bekker L | Roux S | Naicker N | Latka M | Corey L | Kublin J | Gray G
Volume: 6
Issue: Suppl 3
Year: 2009
P14-06. Phase 1 safety and immunogenicity randomised controlled trial of a vaginal gp140 vaccine

Author(s): Lewis DJ | Lacey CJ | Jeffs S | Cole T | Fraser C | Wiggins R | Woodrow M | Cope A | Cai C | Giemza E | Mahmhoud A | Katinger D | Cranage M | Shattock R
Volume: 6
Issue: Suppl 3
Year: 2009
P14-05. Recruitment, retention and participation impact events among women participating in phase III community trial in Thailand

Author(s): Pitisuttithum P | Rerks-Ngarm S | Kaewkungwal J | Nitayaphan S | Khamboonruang C | Kunasol P | Suntharasamai P | Benenson MW | Kim JH
Volume: 6
Issue: Suppl 3
Year: 2009
P14-04. HIV-SELECTEST EIA and rapid test: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies

Author(s): Khurana S | Norris PJ | Busch MP | Mlisana K | Salim AK | Hunter E | Golding H
Volume: 6
Issue: Suppl 3
Year: 2009
P14-03. HIV-specific T-lymphocyte proliferative responses induced by a multigene multiclade HIV-1 DNA/MVA heterologous vaccine in Tanzanian volunteers

Author(s): Aboud S | Mhalu F | Bakari M | Lifson J | Lyamuya E | Marovich M | Cox J | Sandstrom E | Biberfeld G | Nilsson C
Volume: 6
Issue: Suppl 3
Year: 2009
P14-02. Social impact events in Phambili, the first phase 2B HIV vaccine trial in South Africa

Author(s): Allen MA | Gray G | Churchyard G | Bekker L | Nchabeleng M | Mlisana K | Metch B | Moodie Z | Roux S | Mathebula M | Bennie T | Kublin J
Volume: 6
Issue: Suppl 3
Year: 2009
P03-02. SCID-hu mice generate HIV specific human immune responses after gp96 vaccination

Author(s): Gonzalez LE | Strbo N | Podack ER
Volume: 6
Issue: Suppl 3
Year: 2009
P14-01. Care and treatment for volunteers in IAVI-sponsored HIV vaccine clinical trials in India

Author(s): Kochhar S | Excler J | Fast P
Volume: 6
Issue: Suppl 3
Year: 2009
P13-06. DARPin-based microbicide strategies to block HIV entry

Author(s): Mann A | Krarup A | Trkola A
Volume: 6
Issue: Suppl 3
Year: 2009
P13-05. Factors associated with pregnancy during the HVTN 503/Phambili trial, a phase IIB HIV trial of the Merck Ad-5 multi-clade HIV vaccine

Author(s): Latka M | Grey G | Fielding K | Bekker L | Mlisana K | Nchabeleng M | DeBruin G | Allen M | Kublin J | Churchyard G
Volume: 6
Issue: Suppl 3
Year: 2009
P13-04. HIV positive women empowerment is equal to hiv prevalence reduction

Author(s): Akolo MM | Kimani J | Barassa S | Lipesa S | Gelmon I
Volume: 6
Issue: Suppl 3
Year: 2009
P13-03. Neutralizing antibody to HIV-1 Env from hyperimmune bovine colostrum as a mucosal microbicide strategy for preventing virus transmission

Author(s): Kramski M | Center R | Rawlin G | Siebentritt C | Purcell DF
Volume: 6
Issue: Suppl 3
Year: 2009
P13-02. Cytoskeletal proteins bound to HSP70 may elicit resistance to SIV infection of CD4+ T cells

Author(s): Bergmeier L | Babaahmady K | Pido-Lopez J | Heesom K | Kelly CG | Whittall T | Lehner T
Volume: 6
Issue: Suppl 3
Year: 2009
P13-01. Crystal structure and function of a monoclonal antibody against primate CD4 that blocks HIV/SIV infection

Author(s): Pegu A | Boyington JC | Kong W | Shi W | Kwong PD | Nabel GJ
Volume: 6
Issue: Suppl 3
Year: 2009
P12-16. Biochemical and immunological characterization of the plant-derived candidate HIV-1 mucosal vaccine CTB-MPR

Author(s): Matoba N | Cherni I | Kessans S | Frater J | Preston K | Bomsel M | Mor TS
Volume: 6
Issue: Suppl 3
Year: 2009
P12-15. Replication enhancement of an alphaviral-lentiviral replicating chimeric particle (RCP) vaccine

Author(s): Young K | Beard C | Johnston R
Volume: 6
Issue: Suppl 3
Year: 2009
P12-14. Design of hydrophilic, helical peptides that mimic the 4E10 epitope of HIV-1 gp41

Author(s): Lorenz IC | Martin CL | Hoffenberg S | Phogat SK | Kaminsky SM
Volume: 6
Issue: Suppl 3
Year: 2009
P03-01. The relationship of envelope evolution to lentiviral persistence and vaccine efficacy

Author(s): Craigo JK | Issel CJ | Montelaro RC
Volume: 6
Issue: Suppl 3
Year: 2009
P12-13. Structure-guided design and immunological characterization of immunogen constructs presenting the HIV-1 gp120 V3 loop on a CTB scaffold

Author(s): Totrov M | Jiang X | Kong X | Cohen S | Krachmarov C | Williams C | Cardozo T | Gorny M | Wang S | Lu S | Pinter A | Zolla-Pazner S
Volume: 6
Issue: Suppl 3
Year: 2009
P12-12. Analysis of antibody and B cell responses following inoculation with computationally designed HIV-1 2F5 epitope scaffold proteins

Author(s): Dosenovic P | Guenaga J | Ofek G | Baker D | Schief W | Kwong PD | Hedestam GB | Wyatt RT
Volume: 6
Issue: Suppl 3
Year: 2009
P12-11. Resistance to the CD4 mimetic mini protein M48-U1 induces changes in a highly conserved region on the HIV-1 gp120 envelope protein

Author(s): Grupping K | Heyndrickx L | Michiels J | Martin G | Martin L | Vanham G
Volume: 6
Issue: Suppl 3
Year: 2009
P12-10. Immunogen utilizing the stable interaction of cytoplasmic tails of HIV-1 envelope and cores

Author(s): Takahashi H | Tobiume M | Sata T
Volume: 6
Issue: Suppl 3
Year: 2009
P12-09. Immune responses in controlled and uncontrolled HIV infection to a designed HIV immunogen sequence focused on conserved regions of the viral genome

Author(s): Mothe B | Llano A | Ibarrondo J | Miranda C | Rolland M | Frahm N | Khatri A | Heckerman D | Mullins J | Brander C
Volume: 6
Issue: Suppl 3
Year: 2009
P12-07. Novel HIV vaccines using chimeric influenza HA vectors

Author(s): Steinhauer DA | Langley WA | Talekar G | Li Z
Volume: 6
Issue: Suppl 3
Year: 2009
P12-06. A 'non-self' mimic of the natural epitope of anti-HIV antibody 2G12 shows enhanced antigenicity

Author(s): Doores KJ | Fulton Z | Scanlan CN | Wormald MR | Dwek RA | Wilson IA | Burton DR | Davis BG
Volume: 6
Issue: Suppl 3
Year: 2009
P12-05. Using combinatorial phage-display libraries as a source of mimetic peptides of three HIV-1 envelope epitopes

Author(s): Palacios-Rodriguez Y | Gazarian T | Gazarian K
Volume: 6
Issue: Suppl 3
Year: 2009
P12-04. Topology of the C-terminal tail of HIV-1 gp41: Differential exposure of the Kennedy epitope on cell and viral membranes

Author(s): Steckbeck JD | Sturgeon TJ | Sun C | Montelaro RC
Volume: 6
Issue: Suppl 3
Year: 2009
P02-12. Bupivacaine, a local anaesthetic, enhances immunogenicity of a multiepitopic DNA vaccine containing HIV promiscuous CD4 T cell epitopes

Author(s): Rosa DS | Ribeiro SP | Mairena EC | Kalil J | Cunha-Neto E
Volume: 6
Issue: Suppl 3
Year: 2009
P12-03. Generation of novel recombinant HIV-1 glycoproteins for expression on virus like particles

Author(s): Tagliamonte M | Visciano M | Tornesello M | Buonaguro FM | Buonaguro L
Volume: 6
Issue: Suppl 3
Year: 2009
P12-02. Cell-surface display and panning of HIV-1 derived envelope proteins

Author(s): Bruun T | Kliche A | Wagner R
Volume: 6
Issue: Suppl 3
Year: 2009
P16-26. High avidity virus-specific CD4+ T cells are lost during retroviral infection due to interaction with B cells

Author(s): Ploquin MJ | Pike R | Kassiotis G
Volume: 6
Issue: Suppl 3
Year: 2009
P16-25. HIV specific CTL from elite controllers have a unique survival advantage

Author(s): Heath SL | Jiyu J | Bansal A | Sabbaj S | Shacka JJ | Goepfert PA
Volume: 6
Issue: Suppl 3
Year: 2009
P16-24. Crucial contribution of sub-dominant HLA-C allele restricted CTL responses to the control of HIV

Author(s): Ibarrondo J | Zúñiga R | Farfán M | Suarez J | Mothe B | Llano A | Szinger JJ | Hildebrand W | Sánchez J | Korber BT | Brander C
Volume: 6
Issue: Suppl 3
Year: 2009
P16-23. Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance

Author(s): Tenzer S | Wee E | Burgevin A | Stewart-Jones G | Friis L | Lamberth K | Chang C | Harndahl M | Weimershaus M | Gerstoft J | Akkad N | Klenerman P | Fugger L | Jones EY | McMichael AJ | Buus S | Schild H | van Endert P | Iversen AK
Volume: 6
Issue: Suppl 3
Year: 2009
P16-21. Altered T cell homeostasis and activation in HIV-1 elite suppressors with low CD4+ T-cell counts

Author(s): Groves KC | Bibby D | Isaksen A | Deayton J | Anderson J | Orkin C | Stagg AJ | McKnight Á
Volume: 6
Issue: Suppl 3
Year: 2009
P03-08. Protection against SIVmac239 challenge in a rhesus macaque model conferred by a doxycycline dependent attenuated SIVmac239

Author(s): Page M | Berry N | Robinson M | Quartey-Papafio R | Elsley W | Tudor H | Das A | Kleibeuker W | Klaver B | Li B | Manoussaka M | Stebbings R | Cranage M | Berkhout B | Almond N
Volume: 6
Issue: Suppl 3
Year: 2009
P16-19. Statistical design and analysis of the CAVD-VIMC Elispot transfer study 001

Author(s): Huang Y | Sato A | Wood B | Gill D | Kochar N | Tarragona T | Sambor A | Wan H | Levine G | Self S | Koup R | Cox J | Bailer R | Gilmour J
Volume: 6
Issue: Suppl 3
Year: 2009
P16-18. Regulatory T cell frequencies correlate with T cell activation in chronic HIV-1 infection

Author(s): Angin M | Streeck H | Wen F | Pyo A | Trocha A | Toth I | Kwon D | Pereyra F | Alter G | Altfeld M | Walker BD | Addo MM
Volume: 6
Issue: Suppl 3
Year: 2009
P16-17. Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV suppressive activity

Author(s): Almeida J | Sauce D | Price D | Papagno L | Shin S | Moris A | Larsen M | Pancino G | Douek D | Autran B | Saez-Cirion A | Appay V
Volume: 6
Issue: Suppl 3
Year: 2009
P16-16. Gag and Nef specific T-cell responses in HIV-1 infected long-term non-progressors in Uganda

Author(s): Kyosiimire-Lugemwa J | Pala P | Miiro G | Todd J | Kaleebu P | Imami N | Gotch F
Volume: 6
Issue: Suppl 3
Year: 2009
P16-15. Epitope mapping of HIV-specific CD8+ T-cells responses by polyfunctional and proliferation responses reveal distinct specificity defined by function

Author(s): Richmond ME | McKinnon LR | Kiazyk S | Wachihi C | Kimani M | Kimani J | Plummer FA | Ball TB
Volume: 6
Issue: Suppl 3
Year: 2009
P16-14. Loss of balance between CD4+ regulatory T cell and Th17 population in chronic HIV infection

Author(s): Li D | Chen J | Jia M | Hong K | Liu S | Zhang X | Zhao H | Peng H | Zhao Q | Ma P | Wu C | Shao Y
Volume: 6
Issue: Suppl 3
Year: 2009
P16-13. A greater breadth of HIV-1-specific T cell responses detected using mosaic peptides compare to consensus peptides

Author(s): Yang H | Yan H | Li W | Zhang X | Fischer W | Zhang H | Wu H | Korber BT | McMichael AJ | Xu X | Goonetilleke N
Volume: 6
Issue: Suppl 3
Year: 2009
P16-12. Relative dominance of Gag-specific cytotoxic T lymphocytes is associated with viral load inversely in HIV-1 clade B' infected Chinese

Author(s): Jia M | Chen J | Hong K | Liu S | Zhang X | Zhao H | Altfeld M | Walker B | Yu X | Shao Y
Volume: 6
Issue: Suppl 3
Year: 2009
P16-11. HLA-B57/5801 induces preferential CD27 expression on HIV-Gag but not Nef specific central memory CD8+T cells controlling HIV

Author(s): Xie J | Lu W | Samri A | Costagliola D | Schnuriger A | da Silva BC | Blanc C | Almeida M | Pellé O | Theodorou I | Rouzioux C | Autran B
Volume: 6
Issue: Suppl 3
Year: 2009
P03-07. Autologous neutralizing antibodies that select viral escape variants emerge late after SIV infection of rhesus monkeys

Author(s): Yeh WW | Rahman I | Hraber P | Giri A | Nevidomskyte D | Coffey RT | Asmal M | Miljkovic S | Whitney JB | Keele BF | Shaw GM | Korber BT | Seaman MS | Letvin NL
Volume: 6
Issue: Suppl 3
Year: 2009
P16-10. IL-2 therapy mediates expansion of Treg cells, maintains IL-17 expressing CD4+ T-cells and selectively suppresses HIV specific T-cell responses

Author(s): Ndhlovu L | Sinclair E | Epling L | Tan QX | Ho T | Jha AR | Levy JA | Nixon DF | Barbour JD | Hecht FM
Volume: 6
Issue: Suppl 3
Year: 2009
P16-09. Adenovirus 5 vector HIV vaccination does not affect mucosal homing markers on Ad5-specific CD4+ T-cells in humans

Author(s): Hutnick N | Carnathan D | Dubey S | Cox K | Ratcliffe S | Robertson MN | Casimiro DR | Ertl HC | Betts MR
Volume: 6
Issue: Suppl 3
Year: 2009
P16-08. Combined blockade of the PD-1 and IL-10 pathways synergistically enhance HIV-specific CD4 T cell functions

Author(s): Porichis F | Kwon DS | Tighe DP | Pavlik DF | Kavanagh DG | Freeman GJ | Walker BD | Kaufmann DE
Volume: 6
Issue: Suppl 3
Year: 2009
P16-07. HLA-B1302 is associated with viral control in clade CRF01_AE HIV-1 infection in Thailand

Author(s): Hempel U | Buranapraditkun S | Chatkulkawin P | Pitakpolrat P | Phillips LC | Allgaier RL | Lorenzen S | Hildebrand WH | Leitner T | Matthews P | Goulder P | Walker BD | Ruxrungtham K | Allen TM
Volume: 6
Issue: Suppl 3
Year: 2009
P16-06. Control of HIV-1 by HIV-1 Pol-specific CD8+ T cells in chronically HIV-1-infected Japanese cohort

Author(s): Murakoshi H | Gatanaga H | Koyanagi M | Oka S | Takiguchi M
Volume: 6
Issue: Suppl 3
Year: 2009
P16-05. Upregulation of PD-1 and CTLA-4 on HIV-specific T cells in HIV-infected infants

Author(s): Nqoko BS | Day C | Mansoor N | de Kock M | Hughes J | Hussey G | Hanekom W
Volume: 6
Issue: Suppl 3
Year: 2009
P16-04. Cryptic CTL epitopes derived from antisense transcription are frequently recognized in HIV-1 infection

Author(s): Bansal A | Carlson J | Matthews P | Akinsiku O | Yan J | Sabbaj S | Heath S | Goulder P | Heckerman D | Goepfert P
Volume: 6
Issue: Suppl 3
Year: 2009
P16-03. Persistence of robust cross-reactive group M consensus T-cell responses in a chronic HIV-1 clade A1 and D-infected Ugandan population

Author(s): Serwanga JJ | Mugaba S | Pimego EE | Lyagoba FF | Nanteza BB | Katongole EM | Ndembi NN | Kaleebu PP
Volume: 6
Issue: Suppl 3
Year: 2009
P16-02. Induction of systemic HIV-1 specific cellular immune responses by oral exposure in exposed uninfected partner of discordant couples

Author(s): Pérez C | Hasselrot K | Broliden K | Karlsson A
Volume: 6
Issue: Suppl 3
Year: 2009
P16-01. Regulatory T-cells and high levels of FOXP3 mRNA leads to decreased immune responses in HIV-TB co-infection

Author(s): Loxton A | Roberts T | Black G | Walzl G
Volume: 6
Issue: Suppl 3
Year: 2009
P03-06. Preserved cellular and humoral immune responses in macaques infected with SIVmac239 and subjected to early antiretroviral therapy

Author(s): Makitalo B | Walther-Jallow L | Sahin G | Michaelsson J | Spangberg M | Thorstensson R | Fenyo E | Spetz A
Volume: 6
Issue: Suppl 3
Year: 2009
P15-28. Attitudes and awareness of HIV vaccine research in HIV uninfected MSM in four US cities: Rochester, Boston, San Francisco and Philadelphia

Author(s): Alexander SB | Bunce CA | Lanier M | Maynard J | Morrow-Hall G
Volume: 6
Issue: Suppl 3
Year: 2009
P15-27. Community involvement and ethics in HIV vaccine trial in Nigeria

Author(s): Adeyemi AO | Fakunle O | Adesola OA | Olaogun O
Volume: 6
Issue: Suppl 3
Year: 2009
P15-26. Leveraging motivators to participation in HIV vaccine research in the age of Obama

Author(s): Alexander SB | Im S
Volume: 6
Issue: Suppl 3
Year: 2009
P15-25. Preparation for HIV vaccine trials in Africa: barriers and facilitators for the establishment of a community advisory board in Burkina Faso

Author(s): Berthe A | Meda N | Traoré IT | Some J | Salouka S | Sanou L | Some F | Rouamba J | Ouedraogo D | M'Boutiki G | Mayaud P | Nagot N | perre P
Volume: 6
Issue: Suppl 3
Year: 2009
P15-24. Good participatory practice guidelines begin to take root

Author(s): Miller L | Bass E | Warren M | Grant D | Costelloe-Kuehn A | Feuer C | Fisher K
Volume: 6
Issue: Suppl 3
Year: 2009
P15-23. Community engagement strategies in the Canadian HIV vaccine initiative

Author(s): Milsom P | Cryan C | Sternthal S | Harmston C
Volume: 6
Issue: Suppl 3
Year: 2009
P15-22. Potential synergies between HIV vaccines, microbicides and pre-exposure prophylaxis

Author(s): Sarazin V | Milsom P
Volume: 6
Issue: Suppl 3
Year: 2009
P15-21. Investigating the utility and relevance of the good participatory practice guidelines for biomedical HIV prevention trials

Author(s): Miller L | Bass E | Warren M | Fisher K | Grant D | Feuer C
Volume: 6
Issue: Suppl 3
Year: 2009
P15-20. Developing a national policy agenda for the Canadian HIV vaccine initiative

Author(s): Sarazin V | Jonsdottir L | Sternthal S | Roblin K | Grundy S
Volume: 6
Issue: Suppl 3
Year: 2009
P15-19. Evaluating community engagement efforts in a large, multi-site, global HIV vaccine trials network

Author(s): Maggard K | Broder G | Maclachlan E | None A
Volume: 6
Issue: Suppl 3
Year: 2009
P03-05. CD4 targeted vaccination in retroviral infection

Author(s): Pike R | Ploquin MJ | Kassiotis G
Volume: 6
Issue: Suppl 3
Year: 2009
P15-18. Behavioral and social science in HIV vaccine clinical research: workshop recommendations

Author(s): Lau C | Swann EM | Gaist P | Allen MA
Volume: 6
Issue: Suppl 3
Year: 2009
P15-17. Social media as a tool for engaging and educating audiences around HIV vaccine research and clinical trial participation

Author(s): Sitar S | Hartman BI | Graham BS | Ledgerwood JE
Volume: 6
Issue: Suppl 3
Year: 2009
P15-16. Social factors affecting retention rates in Step study participants in Lima-Peru

Author(s): Fernandez-Maldonado MD | Segura P | Lama JR | Sanchez J
Volume: 6
Issue: Suppl 3
Year: 2009
P15-15. Advocates' perspectives on community engagement in the HVTN 505

Author(s): Warren M | Bass E | Feuer C | Fisher K | Grant D | Miller L
Volume: 6
Issue: Suppl 3
Year: 2009
P15-14. Assuring data quality of the phase III vaccine trial of ALVAC vaccine priming and AIDSVAX vaccine boosting in Thailand

Author(s): Kaewkungwal J | Pitisuttithum P | Nitayapan S | Khamboonruang C | Khamboonruang C | Thongchareon P | Kunasol P | Benenson M | Kim J
Volume: 6
Issue: Suppl 3
Year: 2009
P15-13. HVTN 503(Phambili) trial discontinuation of enrolment/vaccination: the impact on trial participant attitudes to vaccine trials and scientific research

Author(s): Mark D | Middelkoop K | Roux S | Gray G | Mlisana K | Nchabaleng M | Churchyard G | De Bruyn G | Latka M | Magagula D | Kublin J | Allen M | Bekker L
Volume: 6
Issue: Suppl 3
Year: 2009
P15-11. Preventive HIV vaccine acceptability: a systematic review and meta-analysis

Author(s): Newman PA | Logie C
Volume: 6
Issue: Suppl 3
Year: 2009
P04-02. Increased breadth and potency of the neutralizing antibody response among dually-HIV-1-infected individuals

Author(s): Powell RL | Kinge T | Nyambi P
Volume: 6
Issue: Suppl 3
Year: 2009
P01-03. Regulatory T cells and TH-17 cells counterbalance in CD4+ T cell activation in HIV-1-infected subjects progressing to immunodeficiency

Author(s): Carvalho KI | Romano FB | Matos AM | Kallas EG
Volume: 6
Issue: Suppl 3
Year: 2009
P17-17. Newborn mice vaccination with rBCG:HIVA + MVA:HIVA enhances HIV-1-specific immune responses. Influence of age and immunization routes

Author(s): Saubi N | Im E | Fernandez-Lloris R | Gil O | Cardona P | Gatell J | Hanke T | Joseph J
Volume: 6
Issue: Suppl 3
Year: 2009
P17-16. Anti-Langerin-HIV Gag p24 fusion protein targeting Langerhans cells as a new anti-HIV vaccine strategy

Author(s): Culina S | Zurawsky G | Flamar A | Brochard P | Delache B | Banchereau J | Le Grand R | Martinon F
Volume: 6
Issue: Suppl 3
Year: 2009
P17-15. Immunogenicity studies of chimeric yellow fever 17D viruses carrying HIV-1 p24 antigen

Author(s): Franco D | Rosas C | Rice CM | Ho DD
Volume: 6
Issue: Suppl 3
Year: 2009
P17-14. Fitness-informed HIV-1 Gag-p24 vaccine design

Author(s): Rolland MM | Swain VJ | Lanxon-Cookson E | Rao U | Henry KR | Arts EJ | Nickle DC | Mullins JI
Volume: 6
Issue: Suppl 3
Year: 2009
P17-13. Hexon hypervariable regions 4–7 contain important Ad5-specific neutralizing antibody epitopes

Author(s): Bradley RR | Maxfield LF | Barouch DH
Volume: 6
Issue: Suppl 3
Year: 2009
P17-11. HIV DNA vaccine delivery in association with electroporation in the skin of nonhuman primates

Author(s): Culina S | Mannioui A | Kaldma K | Sikut R | Adojaan M | Männik A | Toots U | Kivisild T | Stanescu I | Ustav M | Le Grand R | Martinon F
Volume: 6
Issue: Suppl 3
Year: 2009
P17-10. A new AuxoGTU-HIV B DNA vaccine induce very long lasting HIV specific T cells response which is efficiently boosted with HIV LAI lipopeptides

Author(s): Mangeot-Méderlé I | Sylla N | Corneau A | Langlois S | Sikut R | Kaldma K | Stanescu I | Ustav M | Lévy Y | Derreudre-Bosquet N | Le-Grand R | Martinon F
Volume: 6
Issue: Suppl 3
Year: 2009
P17-09. Immunization with a single HIV-1 envelope sequence can generate CD8+ T lymphocytes capable of recognizing multiple variant forms of envelope

Author(s): Hulot SL | Seaman MS | Dorosh LA | Korber BT | Letvin NL
Volume: 6
Issue: Suppl 3
Year: 2009
P17-08. Transduction of human monocyte-derived dendritic cells by recombinant adeno-associated virus

Author(s): Ussher JE | Taylor JA
Volume: 6
Issue: Suppl 3
Year: 2009
P04-01. Simultaneous enumeration of HIV-1 gp41 Env-specific IgG and IgM antibody-secreting cells with a multiplex B-cell fluorospot assay

Author(s): Bonsignori M | Hwang K | Vandergrift N | Moody MA | Haynes BF
Volume: 6
Issue: Suppl 3
Year: 2009
P17-07. Insertion of a vaccinia virus host range (hr) gene into NYVAC-B genome potentiates immune responses against HIV-1 antigens

Author(s): Najera JL | Gomez CE | Garcia-Arriaza J | Esteban M
Volume: 6
Issue: Suppl 3
Year: 2009
P17-06. Development of a replication-defective Herpes Simplex virus 1 recombinant expressing HIV-1 clade A envelope protein

Author(s): Sen J | Liu X | Mathews L | Bryant K | Knipe D
Volume: 6
Issue: Suppl 3
Year: 2009
P17-05. Dealing with HIV-1 diversity

Author(s): Rosario M | Borthwick N | Bridgeman A | Watkins D | Colloca S | Quakkelaar ED | Liljestrom P | Nicosia A | Melief CJ | Hanke T
Volume: 6
Issue: Suppl 3
Year: 2009
P17-04. Targeting HIV peptides to human dendritic cells via CD40 elicits expansion of multi-epitope polyfunctional CD4+ and CD8+ T cells in HIV patients

Author(s): Flamar A | Zurawski S | Cobb A | King B | Sloan L | Levy Y | Banchereau J | Zurawski G
Volume: 6
Issue: Suppl 3
Year: 2009
P17-03. Nanoengineered layer-by-layer capsules as a novel delivery system for HIV vaccines

Author(s): Sexton A | Whitney PG | De Rose R | Zelikin AN | Chong S | Johnston AP | Caruso F | Kent SJ
Volume: 6
Issue: Suppl 3
Year: 2009
P17-02. PolyCTLDesigner: the software for constructing highly efficient polyepitope immunogens. Application to HIV-1

Author(s): Antonets D | Maksyutov A | Bazhan S
Volume: 6
Issue: Suppl 3
Year: 2009
P17-01. HIV-specific immune responses induced by a single dose of HIV DNA vaccine in Rhesus macaques

Author(s): Arrode-Brusés G | Sheffer D | Hegde R | Liu Z | Villinger F | Narayan O | Chebloune Y
Volume: 6
Issue: Suppl 3
Year: 2009
P16-53. Distinct subsets of memory T lymphocytes from HIV-1-infected subjects secrete IFN-γ and IL-2 in response to novel CD4+ T-cell HIV-1 epitopes

Author(s): Fonseca S | Coutinho-Silva A | Rodrigues D | Marti L | Moreira-Filho C | Segurado A | Kallás E | Kalil J | Cunha-Neto E
Volume: 6
Issue: Suppl 3
Year: 2009
P16-52. HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism

Author(s): Manches O | Munn D | Fallahi A | Lifson J | Chaperot L | Plumas J | Bhardwaj N
Volume: 6
Issue: Suppl 3
Year: 2009
P16-51. Functional characterization of novel SIV epitope specific T cells

Author(s): Winstone N | Mullen K | Wilson A | McDermott A
Volume: 6
Issue: Suppl 3
Year: 2009
P03-11. DNA vaccination with IL-12 lowers viral replication following SIVmac251 challenge

Author(s): Hirao LA | Wu L | Khan AS | Dai A | Karl J | Lank S | Wiseman R | O'Connor D | Watkins D | Miller N | Betts MR | Sardesai NY | Boyer JD | Weiner DB
Volume: 6
Issue: Suppl 3
Year: 2009
P16-50. Immune reconstitution and antiviral control of SIV following adoptive transfer of anti-CD3/28 expanded CD4+ T cells: Induction of antiviral control

Author(s): Onlamoon N | Rogers KA | Plagman N | Lewis A | Mayne A | Pattanapanyasat K | Basso L | Orchard P | Ansari AA | Villinger F
Volume: 6
Issue: Suppl 3
Year: 2009
P16-49. Broad types of cytokines secreted by Gag-specific T cells from HIV infected patients on HAART

Author(s): Montes M | Loof N | Cobb A | Jutras D | Quinn C | Plants J | Zurawski S | King B | Sloan L | Levy Y | Banchereau J
Volume: 6
Issue: Suppl 3
Year: 2009
P16-48. Immunologic and virologic characterization of an ART-treated HIV-1 patients cohort with long-term control of viremia

Author(s): Kinloch S | Cellerai C | Yerly S | Byrne P | Carroll A | Stauss H | Johnson A | Harari A | Pantaleo G
Volume: 6
Issue: Suppl 3
Year: 2009
P16-47. Interleukin (IL)-21 induces cytolytic molecule perforin in CD4 and CD8 T cells without CD4 activation in chronically SIV infected rhesus macaques

Author(s): Pahwa S | Pallikkuth S | Rogers KA | Doster M | Villinger F | Franchini G
Volume: 6
Issue: Suppl 3
Year: 2009
P16-46. CD8+ T cells from nonlymphoid tissues exhibit superior control of SIV replication

Author(s): Greene JM | Lhost JJ | Burwitz BJ | O'Connor SL | O'Connor DH
Volume: 6
Issue: Suppl 3
Year: 2009
P16-45. High avidity CD4+ T cell response directed to an immunodominant Gag epitope in HIV controllers: an ANRS EP36 study

Author(s): Vingert B | Perez-Patrigeon S | Jeannin P | Lambotte O | Boufassa F | Lemaître F | Kwok WK | Theodorou I | Delfraissy J | Thèze J | Chakrabarti LA
Volume: 6
Issue: Suppl 3
Year: 2009
P16-44. Investigating T cell immune responses in Cameroon, a country with broad HIV-1 genetic diversity

Author(s): Tongo M | Ebong E | Zembe L | Ngole E | Burgers W
Volume: 6
Issue: Suppl 3
Year: 2009
P16-43. A hierarchy of antiviral activity between different epitope-specific CD8+ T cells can be attributed to early elimination of HIV-infected cells

Author(s): Payne RP | Kloverpris H | Garcia-Prado J | Goulder PJ
Volume: 6
Issue: Suppl 3
Year: 2009
P16-42. Characterisation of HIV-1 specific T-cell responses in exposed uninfected individuals from a London cohort

Author(s): Ritchie AJ | Kopycinski J | Campion S | Moore S | Liu M | Tanner R | Kuldanek K | Legg K | Wang M | Moodie Z | Korber B | Fidler S | McMichael A | Goonetilleke N
Volume: 6
Issue: Suppl 3
Year: 2009
P16-41. Evidence for in vivo immune selection pressure exerted by HLA class I restricted CTL responses to anti-sense encoded HIV sequences

Author(s): Berger CT | Carlson J | Brumme CJ | Brumme ZL | Hartman K | Henry LM | Kadie C | Brockman MA | Harrigan R | Heckerman D | Brander C
Volume: 6
Issue: Suppl 3
Year: 2009
P03-10. Induction of neutralizing antibodies in Rhesus macaques following mucosal challenge with R5 tropic SHIV162P3 isolate

Author(s): Chung H | Galmin L | Suschak J | Weiss D | Finke L | Montefiori D | PAL R
Volume: 6
Issue: Suppl 3
Year: 2009
P16-40. Inhibition of histone deacetylases modulates CD8+ T-lymphocyte mediated virus suppression by HIV-1 viral controllers

Author(s): Saunders KO | Freel SA | Overman R | Cunningham CK | Tomaras GD
Volume: 6
Issue: Suppl 3
Year: 2009
P16-39. T cell recognition of autologous and non-autologous HIV-1 protease peptides by HIV-1 infected patients undergoing PI therapy

Author(s): Moraes SL | Muller NG | Paula MO | Arruda MB | Brindeiro RM | Alencar R | Jamal L | Kalil J | Cunha-Neto E
Volume: 6
Issue: Suppl 3
Year: 2009
P16-38. Transient loss of intestinal CD4+CCR5+ lymphocytes following vaccination with live attenuated SIV indicates modification of T cell repertoire/memory

Author(s): Li B | Stebbings R | Berry N | Page M | Ferguson D | Ham C | Elsley W | Hall J | Almond N
Volume: 6
Issue: Suppl 3
Year: 2009
P16-37. HIV controllers with weak CD8+ T cell responses maintain a tight control of infection despite carrying infectious viruses

Author(s): Saez-Cirion A | Sinet M | Shin S | Urrutia A | Versmisse P | Boufassa F | Rouzioux C | Lambotte O | Venet A | Pancino G
Volume: 6
Issue: Suppl 3
Year: 2009
P16-36. Functional genomic immune profile of SIV DNA vaccines delivered by electroporation and combined with molecular adjuvants

Author(s): Boyer JD | Yin J | Dai A | Belisle S | Hirao L | Palermo R | Hokey D | Yan J | Weiner D
Volume: 6
Issue: Suppl 3
Year: 2009
P16-35. Specific CD4 responses to HIV-1 epitopes in exposed seronegative (ESN) versus infected commercial sex workers

Author(s): Kiguoya MW | Mwanjewe J | Ball B | Makubo K | Kimani J | Fowke K
Volume: 6
Issue: Suppl 3
Year: 2009
P16-34. Low frequency of regulatory T cells in peripheral blood from HIV-1+ elite controllers

Author(s): Brandt L | Benfield T | Fomsgaard A | Karlsson I
Volume: 6
Issue: Suppl 3
Year: 2009
P16-33. Standardized serum-free cryomedia have minimum cytotoxicity and maintain antigen-specific T-cell response

Author(s): Schulz JC | Zimmermann H | Reich A | Kemp-Kampke B | von Briesen H | Germann A
Volume: 6
Issue: Suppl 3
Year: 2009
P16-32. Antigen exposure regulates the balance between proliferating and cytotoxic subsets of virus-specific CD8 T-cells

Author(s): Cellerai C | Perreau M | Rozot V | Enders F | Bart P | Pantaleo G | Harari A
Volume: 6
Issue: Suppl 3
Year: 2009
P16-31. Skewed HIV-1-specific CD4+ Th2 helper cell contribution in progressive HIV-1 infection

Author(s): Chevalier M | Pyo A | Jolin JS | Addo M | Kwon DS | Toth I | Walker B | Streeck H
Volume: 6
Issue: Suppl 3
Year: 2009
P03-09. Preserved adaptive immune responses and limited immune activation in CD4-low SIV-positive sooty mangabeys

Author(s): Mir KD | Milush JM | Brenchley JM | Reeves JD | Gordon SN | Else JG | O'Neill E | Silvestri G | Sodora DL
Volume: 6
Issue: Suppl 3
Year: 2009
P16-30. Induction of Tim-3 expression by the common gamma-chain cytokines IL-2, IL-7, IL-15 and IL-21

Author(s): Jones BR | Ostrowski MA | Lo CA | Mujib S | Hunter DV | Ndhlovu LC | Nixon DF
Volume: 6
Issue: Suppl 3
Year: 2009
P16-29. HIV Nef-specific T cells: Th1/CTL, Th2 and Th17 responses

Author(s): Montes M | Loof N | Cobb A | Jutras D | Queen C | Plants J | King B | Zurawski S | Sloan L | Levy Y | Banchereau J
Volume: 6
Issue: Suppl 3
Year: 2009
P16-28. The first year: early correlates of long-term HIV progression

Author(s): Chattopadhyay PK | Brodie T | Ganesan A | Mascola JR | Michael NL | Roederer M
Volume: 6
Issue: Suppl 3
Year: 2009
P19-25. A vaccine model to prevent the depletion of uninfected bystander CD4 cells during HIV infection

Author(s): Vieillard V | Fausther-Bovendo H | Le Grand R | Debre P
Volume: 6
Issue: Suppl 3
Year: 2009
P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques

Author(s): Stambas J | Sexton A | De Rose R | Reece JC | Alcantara S | Loh L | Moffat JM | Laurie K | Hurt A | Doherty PC | Turner SJ | Kent SJ
Volume: 6
Issue: Suppl 3
Year: 2009
P19-23. Putative prefusion mechanism of HIV-1 Env revealed by ligand-induced quaternary alterations in o-gp140 trimers

Author(s): Moscoso CG | Kan E | Poon S | Sun Y | Martin L | Xing L | Green DJ | Lin F | Barnett S | Srivastava I | Cheng R
Volume: 6
Issue: Suppl 3
Year: 2009
P19-22. CD4-targeted delivery of HIV and CCR5 siRNAs by aptamer-siRNA chimeras suppresses HIV infection in primary cells and in human cervical explants

Author(s): Wheeler L | Basar E | McKernan S | Dykxhoorn D | Lieberman J
Volume: 6
Issue: Suppl 3
Year: 2009
P19-21. Sequence variability in the crown of the V3 loop of the HIV-1 envelope is clustered within a small 3D structural zone

Author(s): Almond D | Kimura T | Kong X | Swetnam J | Zolla-Pazner S | Cardozo T
Volume: 6
Issue: Suppl 3
Year: 2009
P19-20. Allogeneic stimulation of the anti-viral APOBEC3G in human CD4+ T cells and prevention of SHIV infectivity in macaques immunized with HLA antigens

Author(s): Wang Y | Whittall T | Scholler J | Wyatt R | Singh M | Bergmeier LA | Bunnik E | Schuitemaker H | Shaw O | Vaughan R | Pido-Lopez J | Seidl T | Babaahmady K | Yang G | Thorstensson R | Biberfeld G | Lehner T
Volume: 6
Issue: Suppl 3
Year: 2009
P04-06. Evolution of an anti-MPER gp41 antibody response that mediates broad HIV-1 cross-neutralization

Author(s): Gray E | Moore P | Ranchobe N | Abrahams M | Madiga M | Mlisana K | Abdool-Karim S | Williamson C | Morris L
Volume: 6
Issue: Suppl 3
Year: 2009
P19-19. MVA vaccines are efficiently cross-presented by DCs and do not enhance HIV replication in DC/T cell cultures

Author(s): Brandler S | Desdouits M | Ceccaldi P | Lévy Y | Schwartz O | Moris A
Volume: 6
Issue: Suppl 3
Year: 2009
P19-17. Construction of HIV-1 AE subtype gp140 DNA vaccine and immunogenicity evaluation

Author(s): Zhang C | Wan Y
Volume: 6
Issue: Suppl 3
Year: 2009
P19-16. Potential of an HIV-1 Tat fusion protein expressed in tomato as a plant-based HIV vaccine

Author(s): Cueno ME | Hibi Y | Karamatsu K | Yasutomi Y | Laurena AC | Okamoto T
Volume: 6
Issue: Suppl 3
Year: 2009
P19-15. Synthesis of multivalent mimotopes as potential vaccine candidates

Author(s): Go JG | Saludes JP | Hoch JA | Oliver JW | Gervay-Hague J
Volume: 6
Issue: Suppl 3
Year: 2009
P19-14. Recombinant alphavirus replicon particles as a platform to evaluate immunogenicity of early transmitted clade C virus envelopes

Author(s): Franti M | Nandi A | Smith L | Lilja A | Balsitis S | Dey A | Zambonelli C | Srivastava I | Barnett SW
Volume: 6
Issue: Suppl 3
Year: 2009
P19-13. Recombinant proteins carrying peptide mimics of HIV-1

Author(s): Chikaev A | Scherbakova N | Tumanova O | Karpenko L | Ilyichev A
Volume: 6
Issue: Suppl 3
Year: 2009
P19-12. Multimers of llama heavy chain variable domains that bind to the 2F5/4E10 epitope neutralize HIV-1

Author(s): Liu Y | Khatttabi ME | Forsman A | Asaa-Chapman MM | Weiss RA | Langedijk H | Hinz A | Weissenhorn W | de Haard H | Verrips T
Volume: 6
Issue: Suppl 3
Year: 2009
P19-11. Generation of virus-like particles expressing different HIV-1 glycoproteins for induction of broadly neutralizing antibodies

Author(s): Visciano M | Tagliamonte M | Tornesello M | Lopalco L | Buonaguro F | Buonaguro L
Volume: 6
Issue: Suppl 3
Year: 2009
P19-10. Induction of dendritic cell maturation by a liposomally-delivered multivalent HIV vaccine

Author(s): Azizi A | Sirskyj D | Saad A
Volume: 6
Issue: Suppl 3
Year: 2009
P04-05. Requirements for antibody domain exchange explored through mutation of the germline 2G12 antibody

Author(s): Huber M | Le KM | Doores KJ | Burton DR
Volume: 6
Issue: Suppl 3
Year: 2009
P19-09. Site-specific incorporation of an unnatural amino acid into the HIV-1 Env spike

Author(s): Arnett SO | Burton DR
Volume: 6
Issue: Suppl 3
Year: 2009
P19-08. Immunisation with recombinant HLA class I and II, HIV-1gp140 and SIVp27 antigens elicits protection against SHIV-SF162P4 infection in rhesus macaques

Author(s): Mörner A | Schøller J | Bunnik E | Jansson M | Wehlin L | Bergqvist L | Pihlainen E | Shaw O | Seidl T | Wang Y | Bergmeier LA | Singh M | Vaughan R | Yang G | Shao Y | Wyatt RT | Schuitemaker H | Biberfeld G | Thorstensson R | Lehner T
Volume: 6
Issue: Suppl 3
Year: 2009
P19-07. Development of a protective HIV/SIV vaccine based on a self-boosting cytomegalovirus vector

Author(s): Ambagala A | Willer DO | Chan J | Marsh A | Sandstrom P | Pilon R | Fournier J | MacDonald KS
Volume: 6
Issue: Suppl 3
Year: 2009
P19-06. The first hypervariable loop and HIV-1 neutralizing antibodies elicited by gp140 env immunogens

Author(s): Ching LK | Stamatatos L
Volume: 6
Issue: Suppl 3
Year: 2009
P19-05. Use of autologous apoptotic pseudovirus infected cells for vaccination against HIV, evaluation in macaques

Author(s): Koopman G | Beenhakker N | Hofman S | Walther-Jallow L | Mäkitalo B | Mooij P | Heeney JL | Anderson J | Verschoor E | Bogers WM | Spetz A
Volume: 6
Issue: Suppl 3
Year: 2009
P19-04. A synergistic effect of a combined bivalent DNA-protein anti-HIV-1 vaccine containing multiple T- and B-cell epitopes of HIV-1 proteins

Author(s): Ilyichev A | Karpenko L | Lebedev L | Uzhachenko R | Ilyicheva T | Bazhan S
Volume: 6
Issue: Suppl 3
Year: 2009
P19-03. Molecular mechanisms for enhancing the antigenicity of the carbohydrate epitope of the broadly neutralizing anti-HIV-1 antibody 2G12

Author(s): Fulton Z | Doores KJ | Scanlan CN | Wormald MR | Dwek RA | Wilson IA | Davis BG
Volume: 6
Issue: Suppl 3
Year: 2009
P19-02. High protection of female macaques from repeated intravaginal challenges with SHIV-162P3 upon mucosal vaccination with Gp41 subunits-virosomes

Author(s): Bomsel M | Drillet A | Roger M | Amacker M | Mouz N | Lopalco L | Devillers G | Zurbriggen R | Fleury S
Volume: 6
Issue: Suppl 3
Year: 2009
P19-01. Pre-clinical immunogenicity of mosaic Asian AE/B HIV-1 DNA vaccine in mice

Author(s): Sirivichayakul S | Felber B | Kulkarni V | Pavlakis G | Buranapraditkun S | Thantiworasit P | Pitakpolrat P | Allen T | Leitner T | Korber B | Ruxrungtham K
Volume: 6
Issue: Suppl 3
Year: 2009
P18-11. DALIA: dendritic cell and lipopeptide-induced immunity against AIDS: a phase I trial

Author(s): Banchereau J | Harrod C | Cobb A | Chene G | Sloan L | Palucka K | Levy Y
Volume: 6
Issue: Suppl 3
Year: 2009
P04-04. The specific phospholipid binding and neutralizing activities of the anti-HIV antibody 4E10 are separable

Author(s): Xu H | Scherer E | Song L | Kim M | Holmes MA | Sellhorn G | Kraft Z | Reinherz EL | Burton DR | Stamatatos L | Strong RK
Volume: 6
Issue: Suppl 3
Year: 2009
P18-10. Ability of HIV antigens-pulsed monocyte-derived dendritic cells to induce HIV-specific T cell response: potential use in therapeutic vaccine

Author(s): Silveira GG | Oshiro TM | Almeida A | Finazzo C | Oliveira RM | Duarte AJ | Benard G
Volume: 6
Issue: Suppl 3
Year: 2009
Why do you need a reservation system?      Affiliate Program